HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2015 | 427 | 488 | 87.5% | |
| HF004 | 2016 | 435 | 503 | 86.5% | |
| HF004 | 2017 | 717 | 824 | 87.0% | |
| HF004 | 2018 | 707 | 801 | 88.3% | |
| HF004 | 2019 | 762 | 863 | 88.3% | |
| HF004 | 2020 | 794 | 897 | 88.5% | |
| HF004 | 2021 | 843 | 959 | 87.9% |
